...
机译:在成人肾移植受者中使用NOMEM的CYP3A5基因型和临床因素的预测。
College of Pharmacy Research Institute of Pharmaceutical Sciences Seoul National University 1;
Drug Discovery Laboratory Choongwae Pharma Corporation Kyonggi South Korea;
College of Pharmacy Research Institute of Pharmaceutical Sciences Seoul National University 1;
College of Pharmacy Research Institute of Pharmaceutical Sciences Seoul National University 1;
College of Pharmacy Research Institute of Pharmaceutical Sciences Seoul National University 1;
College of Pharmacy Research Institute of Pharmaceutical Sciences Seoul National University 1;
Department of International Medicine Seoul National University College of Medicine Seoul South;
Department of Surgery Seoul National University College of Medicine Seoul South Korea;
College of Pharmacy Research Institute of Pharmaceutical Sciences Seoul National University 1;
College of Pharmacy Research Institute of Pharmaceutical Sciences Seoul National University 1;
Kidney transplantation; Nonlinear mixed-effect modeling (NONMEM); Pharmacogenetics; Population pharmacokinetics; Tacrolimus;
机译:使用NONMEM对CYP3A5基因型和临床因素进行他克莫司人群药代动力学参数的预测
机译:在成人肾移植受者中使用NOMEM的CYP3A5基因型和临床因素的预测。
机译:根据CYP3A5基因型和临床因素的喉蒿属植物药代动力学在中国成人肾移植受者的临床因素
机译:CYP3A4 * 18B多态性与中国肾移植患者滑石M药代动力学的关系
机译:使用泵参数,解剖学性质和供体接受者特征预测移植后肾功能
机译:在非裔美国人和白人肾脏移植接受者中他克莫司的种群药代动力学和多种CYP3A5基因型。
机译:他克莫司在成人肾脏移植患者中的群体药代动力学:CYP3A5基因型对起始剂量的影响。